ACAN and osteoarthritis: It has been reported that interleukin-1 beta (IL-1β), one of the main cytokines involved in the pathogenesis of osteoarthritis, can inhibit cell proliferation, reduce the synthesis of aggrecan and type II collagen, and increase the expression of MMP-13 in chondrocytes [2, 3].